Explore 3 Stock Ideas & Industry Insights Download Free Report

News

enGene Therapeutics Rebranding Signals Shift Toward Commercialization of Bladder Cancer Gene Therapy

enGene Therapeutics Name Change Reflects Commercial Transition StrategyenGene’s decision to rebrand from enGene Holdings Inc. to enGene Therapeutics Inc. marks a strategic inflection point as the company moves closer to potential commercialization. The name change, effective April 8, 2026, aligns with its evolving identity …

Nitish Kishor | 08 April 2026

Silicon and Steel: Electronic Technology Stocks Stage Broad-Based Surge as Sector Sentiment Turns

The electronic technology sector delivered one of its most synchronised advances in recent memory, with virtually every corner of the hardware supply chain posting robust gains as investors reconsidered the durability of artificial intelligence-driven capital expenditure and the prospects for a recovery in the …

Nitish Kishor | 08 April 2026

Oil Market Repricing: Is the Ceasefire Risk Premium Unwinding Too Fast?

Market Reaction: Aggressive Risk Premium Compression

Nitish Kishor | 08 April 2026

US-Iran Ceasefire Holds, But Lebanon Keeps the Risk Premium Alive

A Ceasefire Defined by What It Excludes

Nitish Kishor | 08 April 2026

Dollar Swings From Cautious Weakness to Sharp Decline as Hormuz Ceasefire Reshapes Markets

From Edge-of-Seat Anxiety to Relief: The Dollar's Two-Day Arc

Nitish Kishor | 08 April 2026

Metal Markets Diverge After Ceasefire as Liquidity Repricing Accelerates

One Ceasefire, Seven Metals, Zero Consensus

Nitish Kishor | 08 April 2026

Global Markets Rally on Ceasefire Momentum as Oil Slumps and Rate Cut Expectations Rebuild

Market Movers:On Tuesday, the top gainers were Corvex, Inc. (+59.31%) and LanzaTech Global, Inc. (52.51%). On the contrary, SMX (Security Matters) Public Limited Co. (-37.31%) and Focus Universal Inc. (-34.23%) declined the most the same day.

Team Kalkine | 08 April 2026